Advances in Pharmaceutical research (APR) is a peer reviewed online open access Journal, which publishes innovative research papers, reviews articles, and clinical studies dealing with Pharmaceutical Sciences (Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest). All manuscripts are subject to rapid peer review. Manuscripts with high-quality standards shall be published without delay.
Manuscripts submitted to Advances in Pharmaceutical Research (APR) are only accepted on the understanding that they are subject to editorial review, and that they have not been, and will not be, published in whole or in part in any other journal during the editorial process.
Papers must be written in English. If English is not authors' native language, the manuscript should be checked by someone proficient in the language before submission. Manuscripts in which English is difficult to understand may be rejected.
The journal will consider the following type of articles:
In research articles, author should include the results of an original research study. The submitted should be able to how the research project was conducted and provide a thorough analysis of the observations during Systematic reviews may also be submitted as research articles.
In clinical study, author must include the methodology and results on a study that was performed within a clinical setting. These studies include both clinical trials and retrospective analyses of a body of existing cases. In all cases, clinical studies should include a description of the patient group that was involved, along with a thorough explanation of the methodology used for the study and the results that were obtained.
The authors are requested to register the clinical trial presented in the manuscript in a public trial registry and include the trial registration number at the end of the abstract. Trials initiated after July 1, 2005, must be registered prospectively before patient recruitment has begun. For trials initiated before July 1, 2005, the trial must be registered before submission.
A review article should contain up-to-date information and comprehensively cover relevant published literature in a particular area. It should preferably be written by scientists who have in-depth knowledge of the topic. All format requirements are same as those applicable to full papers.
All manuscripts should be arranged in following structure:
Title and Authorship Information
The following information should be included:
The manuscript should contain an abstract, and it should briefly reflect all aspects to the study. The abstract should be citation-free, and should not exceed 250 words.
Four to six appropriate key words should be provided after the abstract.
Short introduction to the research problem followed by a brief review of literature and objective of the research should be provided, and this section should be concise with no subheadings.
Materials and Methods
This part should contain the sufficient details that would enable all procedures to be repeated. It can be divided into subsections if several methods are described.
Results and Discussion
This section should focus on the fulfilment of stated objectives as given in the introduction. It should contain the findings presented in the form of tables, figures and photographs. This section may be divided into subsections or may be combined.
This section should clearly explain the main conclusions of the article, highlighting its importance and relevance.
Conflicts of Interest
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting author is responsible for co-authors declaring their interests.
Authors should state how the research described in their article was funded, including grant numbers if applicable.
All acknowledgments should be included at the very end of the manuscript before the references. Anyone who made a contribution to the research or manuscript, but who is not a listed author, should be acknowledged with their consent.
References must be numbered in order of appearance within the text (including table captions and figure legends) and listed individually at the end of the manuscript. We recommend preparing the references with software package, such as End Note, ReferenceManager or Zotero to avoid typing mistakes and duplicated references. We encourage citations to data, computer code and other citable research material. Include the digital object identifier (DOI) for all references where available.
In the text, reference numbers should be placed within square brackets [ ], and placed before the punctuation; for example , [1–3] or [1, 3]. The reference list should include the full title, as recommended in the Chicago style. References to unpublished peer-reviews, personal communications, including conference abstracts, and papers in preparation or in review, cannot be listed, but can be notated parenthetically in the text.
References should be described as follows, depending on the type of work:
1. M. R. Mehra, M. H. Park, M. J. Landzberg, A. Lala, and A. B. Waxman, “Right heart failure: toward a common language,” The Journal of Heart and Lung Transplantation, vol. 33, no. 2, pp. 123–126, 2014. DOI: http://dx.doi.org/10.1016/j.healun.2013.10.015
For more details use following link-
Preparation of Figures
Upon submission of an article, authors should include all figures and tables in the word file of the manuscript. Figures and tables should not be submitted in separate files. Each figure must be numbered and a short descriptive caption must be provided. A computer drawn figure with good contrast is acceptable. Sometimes, raw data for graphs may be required in Excel sheet when the article is accepted for publication. Graphic files for diagrams and figures may be converted to *.pcx, *.tiff, *.jpg format. These files should not exceed 2 MB in size.
Check list for Figures
If the article is accepted, authors may be asked to provide the source files of the figures. Each figure should be supplied in a separate electronic file.
Preparation of Tables
Tables should be cited consecutively in the text. Every table must have a descriptive title and if numerical measurements are given, the units should be included in the column heading. Vertical rules should not be used.
Check list for Tables
Units of Measurement
Units of measurement should be presented simply and concisely using the International System of Units (SI).
Supplementary materials are the additional parts to a manuscript, such as audio files, video clips, or datasets that might be of interest to readers. Authors can submit one file of supplementary material along with their manuscript through the Manuscript Tracking System. If there is more than one file, they can be uploaded as a .ZIP or .RAR file.
A section titled “Supplementary Material” should be included before the references list with a concise description for each supplementary material file. Supplementary materials are not modified by our production team. Authors are responsible for providing the final supplementary materials file that will be published along with the article.
Proofs will be sent to the corresponding author for final checking. It is the authors’ responsibility to go through the proof meticulously and correct errors if any. Corrections should be restricted to printer’s error only, and no substantial addition/deletion should be made. Corrected proofs must be returned to the journal within two to three days of receipt.
Copyright and Permissions
Authors retain the copyright of their manuscripts, and all Open-Access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. The submitting author is responsible for securing any permissions needed for the reuse of copyrighted materials included in the manuscript.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
In any studies on human or animal subjects, the following ethical guidelines must be observed. For any experiments on humans, all work must be conducted in accordance with the Declaration of Helsinki (1964). Manuscripts describing experimental work which carries a risk of harm to human subjects must include a statement that the experiment was conducted with the human subjects’ understanding and consent, as well as a statement that the responsible Ethical Committee has approved the experiments.
Pharmaceuticals endorse the ARRIVE guidelines (www.nc3rs.org.uk/ARRIVE) for reporting experiments using live animals. Authors and reviewers can use the ARRIVE guidelines as a checklist, which can be found at www.nc3rs.org.uk/ARRIVEchecklist. In the case of any animal experiments, the authors must provide a full description of any anesthetic or surgical procedure used, as well as evidence that all possible steps were taken to avoid animal suffering at each stage of the experiment.
Manuscripts should be submitted by one of the authors of the manuscript through the online Manuscript Processing System (MPS). Only electronic Word (.doc, .docx, .rtf) files can be submitted through the MPS, and there is no page limit. Submissions by anyone other than one of the authors will not be permissible. The submitting author takes responsibility for the manuscript during submission and peer review. If, because of some technical reasons, the submission through Manuscript Management System is not possible, the author can contact email@example.com for support.
Terms of Submission
Manuscripts must be submitted on the understanding that they have not been published elsewhere and are only being considered by this journal. The submitting author is responsible for ensuring that the article’s publication has been approved by all the other co-authors. It is also the submitting author’s responsibility to ensure that the article has all necessary institutional approvals. Further correspondence and proofs will be sent to the author(s) before publication, unless otherwise indicated. It is a condition of submission that the authors permit editing of the manuscript for readability. All inquiries concerning the publication of accepted manuscripts should be addressed to firstname.lastname@example.org. All submissions are bound by our terms of service.
All manuscripts are subject to double blind peer review and are expected to meet the standards of academic excellence.
Article Processing Charges
Presently, there is no article processing charge.